DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...

Royalty Rates in Pharmaceutical and Biotechnology Deals 2010-2025- Product Image Royalty Rates in Pharmaceutical and Biotechnology Deals · GlobeNewswire Inc. Royalty Rates in Pharmaceutical and ...

DUBLIN--(BUSINESS WIRE)--The "Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2020-2025" has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive ...

The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...

(MENAFN- GlobeNewsWire - Nasdaq) Dublin, March 12, 2026 (GLOBE NEWSWIRE) -- The "Preclinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026" report has been added ...

Dublin, March 12, 2026 (GLOBE NEWSWIRE)-- The "Clinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026" report has been added to ResearchAndMarkets.com's offering ...

Dr. Wang Xin, Global Partner and President of Sullivan Greater China, together with Professor Yu Wang, Expert Advisor to the Judging Committee and Chairman of Chinese Foundation for Hepatitis ...

Dublin, March 12, 2026 (GLOBE NEWSWIRE)-- The "Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2026" report has been added to ResearchAndMarkets.com's offering. The Asset Purchase Deals ...

Considering the debt-to-equity ratio in industry comparisons allows for a concise evaluation of a company's financial health and risk profile, aiding in informed decision-making.

Eli Lilly LLY announced that it has entered into a definitive agreement to acquire U.K.-based Centessa Pharmaceuticals CNTA.

Dublin, March 12, 2026 (GLOBE NEWSWIRE)-- The "Preclinical Stage Partnering Terms and Agreements in Pharmaceuticals and Biotechnology 2020-2026" report has been added to ResearchAndMarkets.com's ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to take a look at where Ultragenyx Pharmaceutical, Inc. (NASDAQ:RARE) stands ...